So if you are so down on this stock why don't you leave? You are not down on it, in fact you love it and want others shares. Don't you? You just want a better price that's all. I bought more last week so you don't get them. I will buy more this week as well. Up on my purchase as well.
You still have not provided any proof that NVAX even existed 25 or 26 or27 years ago. I am not sure how many years because you keep changing your mind. I have asked you several times but you don't asnswer because you can't. Your credability is O. Have a great weekend.
You spend too much attacking others and not enough time knowing about your bad investments.
Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The companys technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines. Its vaccine candidates target seasonal influenza, pandemic (H5N1) influenza, and respiratory syncytial virus (RSV). The company, through its joint venture, CPL Biologics Private Limited, engages in developing seasonal and pandemic influenza, and rabies vaccine candidates. The company has a licensing agreement with LG Life Sciences, Ltd. to use the companys VLP technology to develop and sell the influenza vaccines in South Korea and other countries; and a clinical development agreement with PATH Vaccine Solutions to develop RSV vaccine candidate. The company was founded in 1987 and is headquartered in Rockville, Maryland.